These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26935454)

  • 1. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study.
    Van Assche G; Peyrin-Biroulet L; Sturm A; Gisbert JP; Gaya DR; Bokemeyer B; Mantzaris GJ; Armuzzi A; Sebastian S; Lara N; Lynam M; Rojas-Farreras S; Fan T; Ding Q; Black CM; Kachroo S
    Dig Liver Dis; 2016 Jun; 48(6):592-600. PubMed ID: 26935454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.
    Gibson PR; Vaizey C; Black CM; Nicholls R; Weston AR; Bampton P; Sparrow M; Lawrance IC; Selby WS; Andrews JM; Walsh AJ; Hetzel DJ; Macrae FA; Moore GT; Weltman MD; Leong RW; Fan T
    J Crohns Colitis; 2014 Jul; 8(7):598-606. PubMed ID: 24345767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
    Peyrin-Biroulet L; Van Assche G; Sturm A; Gisbert JP; Gaya DR; Bokemeyer B; Mantzaris GJ; Armuzzi A; Sebastian S; Lara N; Lynam M; Rojas-Farreras S; Fan T; Ding Q; Black CM; Kachroo S
    Dig Liver Dis; 2016 Jun; 48(6):601-7. PubMed ID: 27012447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.
    Armuzzi A; Tarallo M; Lucas J; Bluff D; Hoskin B; Bargo D; Cappelleri JC; Salese L; daCosta DiBonaventura M
    BMC Gastroenterol; 2020 Jan; 20(1):18. PubMed ID: 31964359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.
    Solomon D; Yarlas A; Hodgkins P; Karlstadt R; Yen L; Kane S
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1386-96. PubMed ID: 22536781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.
    Teich N; Grümmer H; Jörgensen E; Liceni T; Holtkamp-Endemann F; Fischer T; Hohenberger S
    BMC Gastroenterol; 2021 Apr; 21(1):161. PubMed ID: 33845784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results.
    Teich N; Grümmer H; Jörgensen E; Liceni T; Holtkamp-Endemann F; Fischer T; Hohenberger S
    World J Gastroenterol; 2020 Jun; 26(21):2852-2863. PubMed ID: 32550760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries.
    Armuzzi A; Hart A; Cappelleri JC; Mammar N; Hur P; Hoskin B; Hennessy F; Milligan G; Dignass A
    BMC Gastroenterol; 2023 Jan; 23(1):17. PubMed ID: 36658481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain.
    Targownik L; Dubinsky MC; Steinwurz F; Bushmakin AG; Cappelleri JC; Tai E; Gardiner S; Hur P; Panés J
    J Crohns Colitis; 2023 Apr; 17(4):513-523. PubMed ID: 36271912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine.
    Yarlas A; Yen L; Hodgkins P
    Qual Life Res; 2015 Mar; 24(3):671-83. PubMed ID: 25193617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Real-World Survey in Japan.
    Wang C; Ishizuka T; Tanaka M; Matsuo K; Knight H; Harvey N; Gillespie-Akar L; Gibble TH
    Adv Ther; 2024 Jan; 41(1):431-450. PubMed ID: 37999831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National differences in ulcerative colitis experience and management among patients from five European countries and Canada: an online survey.
    Schreiber S; Panés J; Louis E; Holley D; Buch M; Paridaens K
    J Crohns Colitis; 2013 Jul; 7(6):497-509. PubMed ID: 22921464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA.
    Travis S; Feagan BG; Peyrin-Biroulet L; Panaccione R; Danese S; Lazar A; Robinson AM; Petersson J; Pappalardo BL; Bereswill M; Chen N; Wang S; Skup M; Thakkar RB; Chao J
    J Crohns Colitis; 2017 Oct; 11(11):1317-1325. PubMed ID: 28981846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients.
    Williet N; Sarter H; Gower-Rousseau C; Adrianjafy C; Olympie A; Buisson A; Beaugerie L; Peyrin-Biroulet L
    J Crohns Colitis; 2017 Feb; 11(2):165-174. PubMed ID: 27516406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis.
    Hussey M; Mc Garrigle R; Kennedy U; Holleran G; Kevans D; Ryan B; Breslin N; Mahmud N; McNamara D
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):217-21. PubMed ID: 26587866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.
    Gatopoulou A; Christodoulou DK; Katsanos KH; Bakos D; Mouzas I; Tzouvala M; Theodoropoulou A; Paspatis G; Theocharis G; Thomopoulos K; Giouleme O; Kourikou A; Manolakopoulos S; Zampeli E; Michopoulos S; Karatzas P; Katsaros M; Moschovis D; Orfanoudaki E; Livieratos A; Petrikkou E; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e615-e624. PubMed ID: 34034278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.